This article has Open Peer Review reports available.
Anti-tumor and anti-angiogenic effects of Fucoidan on prostate cancer: possible JAK-STAT3 pathway
© The Author(s). 2017
Received: 5 June 2017
Accepted: 19 July 2017
Published: 1 August 2017
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|5 Jun 2017||Submitted||Original manuscript|
|19 Jun 2017||Reviewed||Reviewer Report - Levent Elmas|
|20 Jun 2017||Reviewed||Reviewer Report - Ahmed Abdel Moneim|
|20 Jun 2017||Reviewed||Reviewer Report - Mücahit Seçme|
|25 Jun 2017||Author responded||Author comments - Xin Rui|
|Resubmission - Version 2|
|25 Jun 2017||Submitted||Manuscript version 2|
|28 Jun 2017||Reviewed||Reviewer Report - Levent Elmas|
|4 Jul 2017||Reviewed||Reviewer Report - Mücahit Seçme|
|Resubmission - Version 3|
|Submitted||Manuscript version 3|
|19 Jul 2017||Editorially accepted|
|1 Aug 2017||Article published||10.1186/s12906-017-1885-y|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.